Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream

  1. Home

  • Saturday, Nov 16th
    9:00 AM – 10:00 AM Eastern Time
    16S02: Emerging Threats in Rheumatology: Chronic Chikungunya Arthritis and Syphilis Mimicking Rheumatic Diseases
    Location: Room 206
    Moderator: Jonathan Miner, MD,PhD – University of Pennsylvania Perelman School of Medicine
    Moderator: Christopher Palma, MD – University of Rochester
    Infection-related rheumatic syndromes
     CME 1 hours
  • Saturday, Nov 16th
    9:00 AM – 9:30 AM Eastern Time
    Airborne Arthritis: Chronic Chikungunya Arthritis - Insights on Clinical Disease, Pathogenesis, and Treatment
    Location: Room 206
    Speaker: Jose Kennedy Amaral Pereira, MD – Federal University of Cariri
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    9:30 AM – 10:00 AM Eastern Time
    Syphilis in Disguise: Unraveling Rheumatic Mimicry and Soaring Infection Rates
    Location: Room 206
    Speaker: Daniela DiMarco, MD,MPH – University of Rochester
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    Infection-related Rheumatic Disease Poster
    Infection-related rheumatic syndromes
     CME 0 hours
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0236: Impact of Socioeconomic Status on Infection-Related Hospitalization Risk in Patients with Systemic Autoimmune Diseases
    Abstract Poster Presenter: Pablo Gamez-Siller, MD – Facultad de Medicina UANL
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0237: Tofacitinib: A Retrospective Study on Safety and Adverse Effects
    Abstract Poster Presenter: Vrushal Kale, MD, MBBS (he/him/his) – P.D. Hinduja Hospital Mumbai
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0238: Longitudinal Assessment of CD8+ T Cell Responses to SARS-CoV-2 Pre- and Post-breakthrough Infection and Its Association with COVID-19 Severity in Immunosuppressed Individuals
    Abstract Poster Presenter: Aljawharah Alrubayyi, PhD – Ragon Institute of Mass General, MIT, and Harvard
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0239: Neutralising Antibody Responses to Bivalent SARS-CoV-2 Vaccines and Hybrid Immunity in Patients on TNF Inhibitors: A Prospective Cohort Study
    Abstract Poster Presenter: Hilde Ørbo, MD – Diakonhjemmet Hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0240: Cellular and Humoral Responses Following a Fifth, Updated SARS-CoV-2 Vaccine Dose and Hybrid Immunity in Patients on TNF Inhibitors: A Prospective Cohort Study
    Abstract Poster Presenter: Hilde Ørbo, MD – Diakonhjemmet Hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0241: Anti-Spike Antibodies in SARS-CoV-2-Vaccinated SLE Patients
    Abstract Poster Presenter: Rebecca Sadun, MD, PhD – Duke University
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0242: Use of Outpatient Antiviral Therapy and Severe Outcomes from SARS-CoV-2 Omicron Infection in Patients with Immune Mediated Diseases on B Cell Depleting Agents
    Abstract Poster Presenter: Cassandra Calabrese, DO – Cleveland Clinic Foundation
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0243: Humoral Response to SARS-CoV-2 Vaccination and Breakthrough COVID-19 Disease in Patients with Immune-mediated Inflammatory Diseases Receiving Biological Treatment
    Abstract Poster Presenter: Eve-Kai Raussi, MD – North Estonia Medical Centre Foundation
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0244: Adjunctive Belimumab Exerts Favorable Ferritin Recovery and Survival for Post-COVID Interstitial Lung Disease in Patients with Immune Mediated Inflammatory Diseases Treated with Rituximab: A Case Series
    Abstract Poster Presenter: Pei-Hsinq Lai, MD – Taipei City Hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0245: The Impact of COVID-19 and ‘Long COVID’ on Self-Reported Disease Activity, Disability, and Quality of Life in Patients with Inflammatory Arthritis
    Abstract Poster Presenter: Zachary Wallace, MD;MSc – Massachusetts General Hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0246: Selectively Targeting TRBV11-2+ T Cells in Multisystem Inflammatory Syndrome in Children (MIS-C) Using Bispecific T Cell-Engaging Antibodies
    Abstract Poster Presenter: Elana Shaw, n/a – The Johns Hopkins University School of Medicine
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0247: Enhanced Immunogenicity of the Recombinant Herpes Zoster Vaccine After One-Week of Mycophenolate Mofetil Discontinuation in Patients with Autoimmune Rheumatic Diseases: Interim Results from a Prospective Randomized Phase 4 Study
    Abstract Poster Presenter: Sandra Pasoto, MD, PhD – Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0248: Recombinant Herpes Zoster Vaccine in a Large Cohort of Autoimmune Rheumatic Diseases Patients: An Interim Analysis of a Prospective Randomized Phase 4 Study
    Abstract Poster Presenter: Nadia Aikawa, MD, PhD – Rheumatology Division and Pediatric Rheumatology Unit, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0249: Real World Evidence on the Safety of the Adjuvanted Recombinant Zoster Vaccine in Patients with Rheumatic Diseases – Preliminary Results from a Prospective Multicenter Observational Greek Study
    Abstract Poster Presenter: Christos Koutsianas, MD – "Hippocration" General Hospital of Athens
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0250: Effectiveness of Tuberculosis Preventive Treatment in Patients with Rheumatic Diseases: A Global Meta-analysis of Cohort Studies
    Abstract Poster Presenter: Beiming Wang, MD – Peking Union Medical College
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0251: T-SPOT.TB and TST in Diagnosing Active Tuberculosis in Patients with Rheumatic Immune Diseases: A Fully Paired Comparative Diagnostic Test Accuracy Study
    Abstract Poster Presenter: Lifan ZHANG, Phd – Peking union medical college hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0252: Prospective Study of Severe Infectious Events and Immune Reconstitution After Rituximab in Autoimmune Diseases
    Abstract Poster Presenter: Aurélien Chepy, MD (he/him/his) – INFINTE U186 inserm, univeristy of Lille
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0253: Outcomes of Respiratory Syncytial Virus Infection in Patients with Systemic Autoimmune Rheumatic Diseases
    Abstract Poster Presenter: Justine Enns, MD – Massachusetts General Hospital
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0254: Rheumatic Manifestations in Patients with Hansen’s Disease Treated with Multidrug Antibiotic Therapy
    Abstract Poster Presenter: Luis Vilá, MD (he/him/his) – University of Puerto Rico Medical Sciences Campus
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0255: “Rheum” to Improve: Have Patients Attending the Young Adult Systemic Erythematosus (YASLE) Clinic Received All Appropriate Vaccinations? A Quality Improvement Initiative
    Abstract Poster Presenter: Razan Al Yaarubi, MD – University of Toronto
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0256: Anti-TNF Therapy as a Potential Risk of Leishmania Infections
    Abstract Poster Presenter: Gloria Albaladejo Paredes, MD (she/her/hers) – Hospital General Universitario Santa Lucía
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0257: High Prevalence of Strongyloides Antibodies in Patients at Risk for Dissemination. A Call for Action
    Abstract Poster Presenter: Jaspreet Bhatti, MD – Westchester Medical Center
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0258: Nationwide Analysis of Adult Non-Gonococcal Bacterial Septic Arthritis Hospitalizations from the National Inpatient Sample 2016 to 2020
    Abstract Poster Presenter: Saman Tanveer, MD – John H. Stroger Jr. Hospital of Cook County
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0259: Whipple’s Disease in Patients Initially Diagnosed with Rheumatic Diseases: A Case Series
    Abstract Poster Presenter: Judith den Hertog, BSc – Sint Maartenskliniek
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0260: National Survey on Patient’s Knowledge and Drivers of Human Papillomavirus (HPV) Vaccination in Immune-mediated Inflammatory Diseases (IMIDs)
    Abstract Poster Presenter: Arthur Mageau, MD, PhD (he/him/his) – Université Paris Cité
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0261: Clinical Implications, Bacterial Profiles, and Patient Outcomes in Hospitalized Patients with Autoimmune Rheumatic Diseases
    Abstract Poster Presenter: Angel Kevin Garza-Elizondo, MD (he/him/his) – Facultad de Medicina, Universidad Autónoma de Nuevo León
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0262: Bartonella Endocarditis as an Important Mimic of ANCA Associated Vasculitis: Results of a Large Single Center Descriptive Analysis
    Abstract Poster Presenter: Adam Brown, MD;BS – Cleveland Clinic Foundation
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0263: Characteristics and Coinfections of Diffuse Alveolar Hemorrhage in Rheumatic Patients
    Abstract Poster Presenter: LUIS EDUARDO BRIONES GARCÍA, MD – Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
    Infection-related rheumatic syndromes
  • Saturday, Nov 16th
    10:30 AM – 12:30 PM Eastern Time
    0264: Clinical Value of Metagenomic Next-generation Sequencing in Patients with Connective Tissue Disease Co-infections: A Single-center Study from Southern Hospital in China
    Abstract Poster Presenter: HanYou Mo, MD – The First Affiliated Hospital of Guangxi Medical University
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    3:00 PM – 4:30 PM Eastern Time
    18M64: Abstracts: Infection-related Rheumatic Disease
    Location: Room 152A
    Abstract Moderator: Anne Bass, MD – Hospital for Special Surgery
    Alternate Moderator: Kimberly S. Lakin, MD, MS – Hospital for Special Surgery
    Abstract Moderator: Leonard Calabrese, DO – Cleveland Clinic
    Alternate Moderator: Jennifer Young-Glazer – Vanderbilt University Medical Center
    Infection-related rheumatic syndromes
     CME 0 hours
  • Monday, Nov 18th
    3:00 PM – 3:15 PM Eastern Time
    2611: Continuation versus Temporary Interruption of Immunomodulatory Agents in Case of an Infection in IRD Patients: Results of a Randomized Controlled Trial
    Location: Room 152A
    Presenting Author: Alfons den Broeder, MD, PhD – Sint Maartenskliniek
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    3:15 PM – 3:30 PM Eastern Time
    2612: Two-Week Methotrexate Discontinuation in Autoimmune Rheumatic Diseases Patients Vaccinated with Recombinant Herpes Zoster Vaccine: An Interim Analysis of a Prospective Randomized Phase 4 Study
    Location: Room 152A
    Presenting Author: Ana Cristina Medeiros-Ribeiro, MD, PhD – Hospital das Clinicas da Faculdade de Medicina da USP
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    3:30 PM – 3:45 PM Eastern Time
    2613: Vaccination Is Associated with Lower Risk of Parenchymal Lung Disease in Patients with Rheumatoid Arthritis After COVID-19: Results from a Prospective Study
    Location: Room 152A
    Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    3:45 PM – 4:00 PM Eastern Time
    2614: Risk of New Onset of Immune-Mediated Diseases After Sars-Cov-2 Infection: A Systematic Review and Meta-Analysis
    Location: Room 152A
    Presenting Author: Julián Barahona-Correa, MD – Pontificia Universidad Javeriana - Hospital Universitario San Ignacio
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    4:00 PM – 4:15 PM Eastern Time
    2615: Prevalence of and Factors Associated with Developing Long COVID Among Patients with Autoimmune Rheumatic Diseases: A Retrospective Cohort Analysis of National U.S. Data
    Location: Room 152A
    Presenting Author: Namrata Singh, MD,MSc – University of Washington
    Infection-related rheumatic syndromes
  • Monday, Nov 18th
    4:15 PM – 4:30 PM Eastern Time
    2616: Associations of Circulating Inflammatory Cytokines with Long COVID Among Patients with Systemic Autoimmune Rheumatic Diseases
    Location: Room 152A
    Presenting Author: Jeffrey Sparks, MD,MSc – Brigham and Women's Hospital
    Infection-related rheumatic syndromes